Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells

MLA

Vicenç Falcó, et al. Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2534a4ca5c5b61b4ab8b09c1474fc5d1&authtype=sso&custid=ns315887.

APA

Vicenç Falcó, Núria Massana, Anna Serrano-Mollar, David Perea, Benjamin Trinité, José Alcamí, María José Soler, Javier García-Pérez, Maria J. Buzon, Marina Suppi, Julià Blanco, Meritxell Genescà, Ander Vergara, Judith Grau-Expósito, & Joel Rosado. (2022). Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells.

Chicago

Vicenç Falcó, Núria Massana, Anna Serrano-Mollar, David Perea, Benjamin Trinité, José Alcamí, María José Soler, et al. 2022. “Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2534a4ca5c5b61b4ab8b09c1474fc5d1&authtype=sso&custid=ns315887.